Syon Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.8M Buy
15,364
+2,229
+17% +$2.63M 0.62% 28
2026
Q2
$15.8M Buy
13,135
+316
+2% +$323K 0.69% 32
2026
Q1
$11.8M Sell
12,819
-51
-0.4% -$51.7K 0.59% 35
2025
Q4
$13.8M Sell
12,870
-383
-3% -$366K 0.69% 30
2025
Q3
$10.1M Buy
13,253
+1,212
+10% +$902K 0.54% 36
2025
Q2
$9.39M Buy
12,041
+371
+3% +$288K 0.62% 31
2025
Q1
$9.6M Buy
11,670
+1,171
+11% +$974K 0.78% 30
2024
Q4
$8.11M Sell
10,499
-763
-7% -$632K 0.73% 28
2024
Q3
$10M Buy
11,262
+127
+1% +$114K 0.88% 21
2024
Q2
$10.1M Sell
11,135
-15
-0.1% -$12K 0.93% 19
2024
Q1
$8.67M Buy
11,150
+362
+3% +$258K 0.82% 21
2023
Q4
$6.29M Buy
10,788
+1,274
+13% +$744K 0.64% 28
2023
Q3
$5.11M Buy
+9,514
New +$4.9M 0.64% 28

Other funds holding LLY

Syon Capital's LLY Position: Q3 2026 in Review

Syon Capital increased its Eli Lilly (LLY) stake by 17% in Q3 2026, buying an estimated $2.63M and bringing the position to 15,364 shares worth $17.8M. The position accounts for 0.62% of the portfolio, ranked #28.

Syon Capital first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Syon Capital held 15,364 shares of Eli Lilly worth $17.8M as of Q3 2026.
  • Syon Capital bought 2,229 Eli Lilly shares in Q3 2026, an estimated $2.63M.
  • Eli Lilly made up 0.62% of Syon Capital's portfolio in Q3 2026, its #28 holding.
  • Syon Capital first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.